World's Best Scientists 2026 revealed!
Hansjakob Furrer

Hansjakob Furrer

Award Badge
Medicine
Switzerland
2023

D-Index & Metrics

Medicine

D-Index
103
Citations
35897
World Ranking
7410
National Ranking
102

Research.com Recognitions

  • 2023 - Research.com Medicine in Switzerland Leader Award

Overview

Hansjakob Furrer is affiliated with the University of Bern in Switzerland. Their research primarily falls within the broad field of Medicine, with a specialized focus on Infectious Diseases, Epidemiology, Virology, Emergency Medicine, and Hepatology.

The scientist's work includes numerous publications across several prominent venues, reflecting contributions to both specialized and clinical domains. Frequent publication venues include Clinical Infectious Diseases, The Journal of Infectious Diseases, Open Forum Infectious Diseases, Journal of Antimicrobial Chemotherapy, and BMC Infectious Diseases.

Among their recent papers are the following:

  • "Cohort Profile Update: The Swiss HIV Cohort Study (SHCS)", 2021, International Journal of Epidemiology
  • "Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV", 2021, Annals of Internal Medicine
  • "A highly virulent variant of HIV-1 circulating in the Netherlands", 2022, Science
  • "Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV", 2022, Zurich Open Repository and Archive (University of Zurich)
  • "Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy", 2023, Clinical Infectious Diseases

Common co-authors collaborating frequently with Hansjakob Furrer include Enos Bernasconi, Huldrych F. Günthard, Matthias Cavassini, Alexandra Calmy, and Andri Rauch.

The main topics of research addressed by the scientist focus extensively on HIV/AIDS, covering areas such as HIV/AIDS Research and Interventions, HIV Research and Treatment, HIV/AIDS drug development and treatment, and HIV-related health complications and treatments.

  • HIV/AIDS Research and Interventions
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • HIV-related health complications and treatments
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Hepatitis C virus research
  • Tuberculosis Research and Epidemiology

Through interdisciplinary work integrating epidemiology, virology, and clinical infectious diseases, Hansjakob Furrer contributes to advancing understanding and treatment strategies in infectious diseases, especially those related to HIV and its associated complications.

Best Publications

  • Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study

    Andri Rauch;Zoltán Kutalik;Zoltán Kutalik;Patrick Descombes;Tao Cai

  • Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.

    Gilbert Greub;Bruno Ledergerber;M. Battegay;P. Grob

  • Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients : a prospective cohort study

    Bruno Ledergerber;Matthias Egger;Milos Opravil;Amalio Telenti

  • Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

    Alison J Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza

  • Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.

    Jacques Fellay;Catia Marzolini;Emma R. Meaden;David J. Back

  • Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis.

    Monika Müller;Simon Wandel;Robert Colebunders;Suzanna Attia

  • Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study

    Barbara Hasse;Bruno Ledergerber;Hansjakob Furrer;Manuel Battegay

  • Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis.

    Martin Feller;Karin Huwiler;Roger Stephan;Ekkehardt Altpeter

  • AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

    Bruno Ledergerber;M. Egger;V. Erard;R. Weber

  • CD4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 Years: The Swiss HIV Cohort Study

    Gilbert R. Kaufmann;Luc Perrin;Guiseppe Pantaleo;Milos Opravil

  • Cohort profile: the Swiss HIV Cohort study

    Franziska Schoeni-Affolter;Bruno Ledergerber;Martin Rickenbach;Christoph Rudin

  • Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients.

    Margalida Rotger;Sara Colombo;Hansjakob Furrer;Gabriela Bleiber

  • Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

    Jacques Fellay;Bruno Ledergerber;Enos Bernasconi;Hansjakob Furrer

  • Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study

    R Weber;M Ruppik;M Rickenbach;A Spoerri

  • Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE).

    Amanda Mocroft;Jens D Lundgren;Jens D Lundgren;Miriam Lewis Sabin;Antonella d'Arminio Monforte

  • Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.

    Gilbert R. Kaufmann;Hansjakob Furrer;Bruno Ledergerber;Luc Perrin

  • Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.

    Hansjakob Furrer;Matthias Egger;Milos Opravil;Enos Bernasconi

  • Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study

    S. Franceschi;M. Lise;G. M. Clifford;M. Rickenbach

  • Factors Associated with the Incidence of Type 2 Diabetes Mellitus in HIV-Infected Participants in the Swiss HIV Cohort Study

    Bruno Ledergerber;Hansjakob Furrer;Martin Rickenbach;Roger Lehmann

  • CD4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 Years

    Gilbert R. Kaufmann;Luc Perrin;Guiseppe Pantaleo;Milos Opravil

Frequent Co-Authors

Enos Bernasconi
Enos Bernasconi Universita della Svizzera Italiana
Manuel Battegay
Manuel Battegay University Hospital of Basel
Matthias Cavassini
Matthias Cavassini University of Lausanne
Pietro Vernazza
Pietro Vernazza University of St. Gallen
Huldrych F. Günthard
Huldrych F. Günthard University of Zurich
Rainer Weber
Rainer Weber University of Zurich
Bruno Ledergerber
Bruno Ledergerber University of Zurich
Amalio Telenti
Amalio Telenti VIR Biotechnology (United States)
Andri Rauch
Andri Rauch University of Bern
Alexandra Calmy
Alexandra Calmy University of Geneva

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The expanding field of medicine opens doors to varied career pathways beyond the traditional MD track. For those interested in nutrition and wellness, pursuing an online bachelor's in nutrition can lead to roles in health coaching, dietetics, and public health education.

A growing number of healthcare professionals are seeking leadership positions by completing cahme accredited mha online programs. These programs provide the flexibility to develop advanced management skills in healthcare settings while balancing work and study commitments.

Registered nurses can quickly advance their careers through rn to bsn online no clinicals accredited programs, enabling them to earn their Bachelor of Science in Nursing fully online without traditional clinical requirements.

For nurses aiming for highest-level practice and leadership, dnp programs online offer an accelerated path to a Doctor of Nursing Practice, focusing on evidence-based practice and executive roles in healthcare.

Best Scientists Citing Hansjakob Furrer

Trending Scientists